IGF-1 Conjugated Sub-5 nm Ultrafine Iron Oxide Nanoparticle Enhances Targeted Drug Delivery and Efficacy of DNA Topoisomerase Inhibitor SN38 for Pancreatic Cancer: An in Vitro Study

MLA

Peijia Xu, et al. IGF-1 Conjugated Sub-5 Nm Ultrafine Iron Oxide Nanoparticle Enhances Targeted Drug Delivery and Efficacy of DNA Topoisomerase Inhibitor SN38 for Pancreatic Cancer: An in Vitro Study. Jan. 2022. EBSCOhost, https://doi.org/10.21203/rs.3.rs-1150109/v1.

APA

Peijia Xu, Ting Xue, Jonathan Padelford, Xingkui Xue, Alyssa Y Wu, Yuancheng Li, & Liya Wang. (2022). IGF-1 Conjugated Sub-5 nm Ultrafine Iron Oxide Nanoparticle Enhances Targeted Drug Delivery and Efficacy of DNA Topoisomerase Inhibitor SN38 for Pancreatic Cancer: An in Vitro Study. https://doi.org/10.21203/rs.3.rs-1150109/v1

Chicago

Peijia Xu, Ting Xue, Jonathan Padelford, Xingkui Xue, Alyssa Y Wu, Yuancheng Li, and Liya Wang. 2022. “IGF-1 Conjugated Sub-5 Nm Ultrafine Iron Oxide Nanoparticle Enhances Targeted Drug Delivery and Efficacy of DNA Topoisomerase Inhibitor SN38 for Pancreatic Cancer: An in Vitro Study,” January. doi:10.21203/rs.3.rs-1150109/v1.